TY - JOUR
T1 - Near infrared fluorescent nanoparticles based on hyaluronic acid
T2 - Self-assembly, optical properties, and cell interaction
AU - Kelkar, Sneha S.
AU - Hill, Tanner K.
AU - Marini, Frank C.
AU - Mohs, Aaron M.
N1 - Funding Information:
This work was supported in part by the National Institutes of Health; P30 CA012197 (Wake Forest University Comprehensive Cancer Center), P30 CA036727 (Fred and Pamela Buffett Cancer Center, UNMC), R00 CA153916 (AMM), and R01 EB019449 (AMM). We thank Dr. David Horita for his expertise and assistance with NMR, Kenneth Gyabaah for microscopy and Mary Beth Laughridge for FACS analysis.
Funding Information:
This work was supported in part by the National Institutes of Health; P30 CA012197 (Wake Forest University Comprehensive Cancer Center), P30 CA036727 (Fred and Pamela Buffett Cancer Center, UNMC), R00 CA153916 (AMM), and R01 EB019449 (AMM). We thank Dr. David Horita for his expertise and assistance with NMR, Kenneth Gyabaah for microscopy and Mary Beth Laughridge for FACS analysis.
Publisher Copyright:
© 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Fluorescent imaging agents that can specifically highlight tumor cells could have a significant impact on image-guided tumor removal. Here, fluorescent nanoparticles (NPs) derived from hyaluronic acid (HA) are investigated. HA is a ligand for the receptor CD44, which is a common biomarker present on many primary tumor cells, cancer-initiating cells, and tumor-associated fibroblasts. In addition, a family of enzymes that degrade HA, called hyaluronidases (HYALs), are also overexpressed with increased activity in many tumors. We report the design and development of a panel of targeted imaging agents using the near-infrared (NIR) dye, Cy7.5, that was directly conjugated to hydrophobically-modified HA. Two different molecular weights of HA, 10 kDa and 100 kDa, and three different degrees of hydrophobic moiety conjugation (0, 10, and 30 mol%) were utilized to develop a panel of NPs with variable size that ranged from 50 to 400 nm hydrodynamic diameter (HD) depending HA molecular weight, extent of fluorescence quenching (25-50%), kinetics of cellular uptake, and targeting to CD44+ cells. The kinetics and energy-dependence of cellular uptake in breast and prostate cancer cell lines, MDA-MB 231 and PC-3 cells, respectively, showed increased uptake with longer incubation times (at 4 and 8 h compared to 1 h), as well as uptake at 37 °C but not 4 °C, which indicated energy-dependent endocytosis. NP uptake studies in the presence of excess free HA showed that pre-treatment of cells with excess high molecular weight (MW) free HA decreased NP uptake by up to 50%, while no such trend was observed with low MW HA. These data lay the foundation for selection of optimized HA-derived NPs for image-guided surgery. Statement of Significance Here, hyaluronic acid (HA), a well-studied biomacromolecule, is modified with a near infrared fluorophore and a hydrophobic moiety. The significance of this work, especially for imaging applications, is that the impact of HA molecular weight and the hydrophobic moiety conjugation degree on fluorescence and cell interaction can be predicted. With respect to existing literature, the eventual use of these HA-based NPs is image-guided surgery; thus, we focus on the dye, Cy7.5, for conjugation, which is more NIR than most existing HA literature. Furthermore, HA is a ligand for CD44, which is associated with cancer and tumor microenvironment cells. Systematic studies in this work highlight that HA can be tuned to maximize or minimize CD44 binding.
AB - Fluorescent imaging agents that can specifically highlight tumor cells could have a significant impact on image-guided tumor removal. Here, fluorescent nanoparticles (NPs) derived from hyaluronic acid (HA) are investigated. HA is a ligand for the receptor CD44, which is a common biomarker present on many primary tumor cells, cancer-initiating cells, and tumor-associated fibroblasts. In addition, a family of enzymes that degrade HA, called hyaluronidases (HYALs), are also overexpressed with increased activity in many tumors. We report the design and development of a panel of targeted imaging agents using the near-infrared (NIR) dye, Cy7.5, that was directly conjugated to hydrophobically-modified HA. Two different molecular weights of HA, 10 kDa and 100 kDa, and three different degrees of hydrophobic moiety conjugation (0, 10, and 30 mol%) were utilized to develop a panel of NPs with variable size that ranged from 50 to 400 nm hydrodynamic diameter (HD) depending HA molecular weight, extent of fluorescence quenching (25-50%), kinetics of cellular uptake, and targeting to CD44+ cells. The kinetics and energy-dependence of cellular uptake in breast and prostate cancer cell lines, MDA-MB 231 and PC-3 cells, respectively, showed increased uptake with longer incubation times (at 4 and 8 h compared to 1 h), as well as uptake at 37 °C but not 4 °C, which indicated energy-dependent endocytosis. NP uptake studies in the presence of excess free HA showed that pre-treatment of cells with excess high molecular weight (MW) free HA decreased NP uptake by up to 50%, while no such trend was observed with low MW HA. These data lay the foundation for selection of optimized HA-derived NPs for image-guided surgery. Statement of Significance Here, hyaluronic acid (HA), a well-studied biomacromolecule, is modified with a near infrared fluorophore and a hydrophobic moiety. The significance of this work, especially for imaging applications, is that the impact of HA molecular weight and the hydrophobic moiety conjugation degree on fluorescence and cell interaction can be predicted. With respect to existing literature, the eventual use of these HA-based NPs is image-guided surgery; thus, we focus on the dye, Cy7.5, for conjugation, which is more NIR than most existing HA literature. Furthermore, HA is a ligand for CD44, which is associated with cancer and tumor microenvironment cells. Systematic studies in this work highlight that HA can be tuned to maximize or minimize CD44 binding.
KW - Cy7.5
KW - Hyaluronic acid
KW - Image-guided surgery
KW - Intraoperative imaging
KW - Near-infrared fluorescence
UR - http://www.scopus.com/inward/record.url?scp=84961262520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961262520&partnerID=8YFLogxK
U2 - 10.1016/j.actbio.2016.03.024
DO - 10.1016/j.actbio.2016.03.024
M3 - Article
C2 - 26995504
AN - SCOPUS:84961262520
SN - 1742-7061
VL - 36
SP - 112
EP - 121
JO - Acta Biomaterialia
JF - Acta Biomaterialia
ER -